
Evidence · Strong & indicated
Fluid & Electrolyte Infusion
Intravenous fluids and electrolytes for dehydration a physician has confirmed, given at a controlled rate when drinking enough is not possible.
30 minutes
IV Therapy & NAD+
The 250 mg NAD+ infusion is our usual starting dose, given slowly at a controlled rate while our medical team monitors you.

This page covers the 250 mg NAD+ infusion, the lower of our two NAD+ doses and the usual starting point. Your first infusion shows how you tolerate NAD+ at a controlled rate before any higher dose is considered. With less NAD+ to deliver at the same rate, the session usually sits at the shorter end of the infusion window. It also suits patients who prefer more frequent, lighter maintenance sessions.
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell. It is central to cellular energy production and is used by enzymes involved in DNA repair (PARPs), circadian rhythm regulation and the sirtuin family of proteins. NAD+ appears to fall with age: in human skin samples, NAD+ levels were lower in older donors than in younger ones (Massudi H et al., PLoS One, 2012). Whether this decline is a cause or a consequence of ageing is still being studied.
The science needs honest framing. In animal studies, raising NAD+ levels has improved mitochondrial function and markers of healthspan. In humans, the picture is less clear. A small 2019 pilot study (Grant R et al., Frontiers in Aging Neuroscience) found that plasma NAD+ did not rise during the first two hours of a slow 6-hour infusion, because the body cleared it so quickly. How much infused NAD+ reaches tissues is still an open question.
Human trials of NAD+ infusion for longevity outcomes have not been completed. We do not have randomised controlled trials showing that NAD+ infusions extend human lifespan or healthspan. What we have is a plausible mechanism, animal evidence and early human pharmacology. We do not offer NAD+ as an anti-ageing treatment, and we make no claim about how it will make you feel.
At Genoryx, NAD+ infusions are given under physician supervision. The infusion runs slowly over 2-3 hours because a faster rate can cause temporary flushing, nausea or chest tightness. These effects settle when the rate is reduced, but they are uncomfortable. Our medical team monitors you throughout and adjusts the rate to your tolerance.
NAD+ infusion is physician-assessed and prescribed only where clinically indicated after screening. It is not a standalone therapy. If it is used at all, it sits inside a programme built on exercise, nutrition, sleep and biomarker tracking. Book a consultation with our longevity physician to discuss whether NAD+ therapy is appropriate for your goals and health status.
Plausible biology and early human data. We tell you what is and is not known. How we grade evidence
What it shows
NAD+ falls with age in human tissue and is central to energy metabolism and DNA repair. Raising it in animals improves several measures of ageing.
What it does not show
In the human pilot study, infused NAD+ did not raise blood NAD+ for the first two hours. No completed trial shows that IV NAD+ improves health outcomes, at either dose.
In skin samples from 49 people, NAD+ fell with age in both men and women.
Pilot study: plasma NAD+ did not rise for the first two hours of a slow infusion. Two authors list commercial NAD+ affiliations.
Review: NAD+ declines with age, but whether restoring it is safe and beneficial in ageing humans is not yet known.
Numbers in brackets point to the studies above. Medical review: a physician who did not write this page checks each line against the source it cites, and checks that nothing reads as a promised result. How we review
A good fit
Talk to us first
No blood test measures whether you need NAD+. These are the safety checks before your first infusion.
Your physician confirms at screening whether this is right for you. If anything above applies, tell us when you book.
Screening
History, current medicines and vitals are checked. Relevant blood work is reviewed before your first infusion.
Prescription
The physician confirms the formulation and rate. Nothing is mixed until it is prescribed for you.
The infusion
A cannula is placed by our medical team and the infusion runs at a controlled rate: 2-3 hours per infusion.
Aftercare
Vitals are rechecked before you leave, and the next session is planned only if it is needed.
Dr. Asritha, MD Anaesthesia, leads the execution of all IV therapy and HBOT protocols, ensuring clinical-grade safety, dosing accuracy, and emergency preparedness for every session.
Meet the clinical teamThe common side effects of NAD+ (flushing, nausea, chest tightness, cramping) are linked mainly to how fast it is infused. Starting at 250 mg lets our medical team find the rate you tolerate. There is no published evidence that a larger single dose gives better long-term results, so we increase the dose only when there is a clinical reason.
Yes, if your physician thinks it is appropriate. Most patients who move up have already had at least one 250 mg infusion without problems. The decision is made at a review, not at the booking desk.
NAD+ is a coenzyme involved in cellular energy production, DNA repair and sirtuin activity, and its levels appear to fall with age. Human trials of health outcomes from NAD+ infusions have not been completed, so we make no claim about benefits. It is prescribed only where a physician finds a clinical reason after screening.
NAD+ IV therapy pricing depends on the dose and protocol duration. We provide transparent pricing during your consultation. NAD+ is a premium therapy due to the clinical-grade formulation and physician-supervised administration required for safe delivery.
NMN (nicotinamide mononucleotide) is an oral NAD+ precursor, and some oral precursors have been shown to raise blood NAD+ in human studies. IV NAD+ bypasses digestion, but a small 2019 pilot study found plasma NAD+ did not rise during the first two hours of a slow infusion, so how much reaches tissues is still unclear. Neither route has been shown to extend human healthspan. Your physician can advise which approach, if any, suits your goals.

Evidence · Strong & indicated
Intravenous fluids and electrolytes for dehydration a physician has confirmed, given at a controlled rate when drinking enough is not possible.
30 minutes

Evidence · Emerging
Intravenous vitamin C, zinc and B vitamins, prescribed after screening when your blood results or a clinical reason support it.
45 minutes

Evidence · Emerging
Intravenous glutathione, given only where a physician finds a clinical indication after screening. Not offered as a cosmetic or anti-ageing treatment.
30-45 minutes
Start with the 400+ parameter entry assessment and a 60-minute physician consultation at either Hyderabad clinic. Open seven days, 11 AM to 9 PM.
Book a consultation